OUP Management as of Dec. 31, 2022
Portfolio Holdings for OUP Management
OUP Management holds 14 positions in its portfolio as reported in the December 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Aerovate Therapeutics Common Stock (AVTE) | 28.9 | $18M | 604k | 29.30 | |
| Centessa Pharmaceuticals Sponsored ADS (CNTA) | 14.9 | $9.1M | 2.9M | 3.10 | |
| PMV Pharmaceuticals Common Stock (PMVP) | 14.1 | $8.6M | 989k | 8.70 | |
| DICE Therapeutics Common Stock | 13.7 | $8.4M | 268k | 31.20 | |
| ionQ Common Stock (IONQ) | 6.6 | $4.1M | 1.2M | 3.45 | |
| Cyteir Therapeutics Common Stock | 6.6 | $4.1M | 2.5M | 1.65 | |
| Vor Biopharma Common Stock (VOR) | 4.1 | $2.5M | 375k | 6.65 | |
| Prime Medicine Common Stock (PRME) | 3.7 | $2.3M | 121k | 18.58 | |
| Graphite Bio Common Stock | 2.2 | $1.3M | 406k | 3.32 | |
| Precision BioSciences Common Stock | 2.2 | $1.3M | 1.1M | 1.19 | |
| Selecta Biosciences Common Stock | 1.6 | $975k | 863k | 1.13 | |
| eFFECTOR Therapeutics Common Stock | 0.7 | $439k | 1.0M | 0.43 | |
| Spero Therapeutics Common Stock (SPRO) | 0.7 | $431k | 249k | 1.73 | |
| Homology Medicines Common Stock | 0.1 | $81k | 64k | 1.26 |
